Clinical TrialID 8277

Comparison of Dopamin Level in Idiopathic Parkinson's Patients

NCT06115538

Parkinson Disease|Treatment Adherence

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8277
Evidence Id
8277
Core Evidence Id
8277
Source Clinical Trial Id
8275
Herb2 Clinical Trial Id
HBCT008275
Nct Id
NCT06115538
Title
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
Status
Enrolling_By_Invitation
Phase
Phase 4
Study Result
No
Study Condition
Parkinson Disease|Treatment Adherence
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
OTHER: Levodopa
Intervention Allocation
Randomized
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
96
Outcome Measure
blood dopamine levels, After the study patients are given levodopa benserazide (100+25 mg) or levodopa carbidopa entacapone (100+25+200 mg), blood samples will be taken from the patients 3 times at 0 minutes and then at 90 and 180 minutes., 0-90-180 minute
Sponsor Collaborator
Ankara Ataturk Sanatorium Training and Research Hospital
Funded By
OTHER_GOV
Location
Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, 063000, Turkey
Other Id
AnkaraAtaturkSTRH-KORUCU-001
Start Date
2023-10-01
Primary Completion Date
2024-10-31
Completion Date
2025-04-30
First Posted
2023-11-03
Results First Posted
Last Update Posted
2023-11-28
Study Document
Study Url
https://clinicaltrials.gov/study/NCT06115538
Title Cn
Title En
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
Bilingual Status
semi_complete